Warning: The NCBI web site requires JavaScript to function. more...
Patenting inventions arising from biological research.
Latimer MT.
Genome Biol. 2005;6(1):203. Epub 2004 Dec 20.
Related citations
Patent prosecution strategies for biotechnological inventions.
Yeh JJ, Fernandez D.
Assay Drug Dev Technol. 2004 Dec;2(6):697-702. Review.
Rewarding true innovation. Experimental use exemption and the trends in gene patenting.
Falciola L.
EMBO Rep. 2000 Sep;1(3):200-3. No abstract available.
[Biotechnological invention patents: a legal-economic analysis].
Pérez-Bustamante G.
Rev Derecho Genoma Hum. 1998 Jan-Jun;(8):159-86. Spanish.
Are DNA patents bad for medicine?
Resnik DB.
Health Policy. 2003 Aug;65(2):181-97.
Nontraditional publications and their effect on patentable inventions.
Garabedian TE.
Nat Biotechnol. 2002 Apr;20(4):401-2. No abstract available.
Patenting inventions in the field of biology and chemistry: German and European patent law and case law.
Vossius V.
Naturwissenschaften. 1997 Oct;84(10):431-43.
Patent protection for protein structures and databases.
Meyers TC, Turano TA, Greenhalgh DA, Waller PR.
Nat Struct Biol. 2000 Nov;7 Suppl:950-2.
Exploiting abstract possibilities: a critique of the concept and practice of product patenting.
Radder H.
J Agric Environ Ethics. 2004;17(3):275-91.
Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA.
William Mary Law Rev. 2003 Dec;45(2):469-547.
Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
Colaianni A, Cook-Deegan R.
Milbank Q. 2009 Sep;87(3):683-715.
Blurred vision.
Smaglik P.
Nature. 2002 Dec 12;420(6916 Suppl):A19, A21, A23. No abstract available.
Patentability and maximum protection of intellectual property in proteomics and genomics.
Warburg RJ, Wellman A, Buck TB, Ligler Schoenhard A.
Pharmacogenomics. 2003 Jan;4(1):81-90. Review.
Biotechnology--a challenge to the patent system.
Farnley S, Morey-Nase P, Sternfeld D.
Curr Opin Biotechnol. 2004 Jun;15(3):254-7. Review.
Inventions in biotechnology and the assessment of obviousness.
Finney K.
Australas Biotechnol. 1994 Sep-Oct;4(5):280-3.
Patent prosecution strategies for stem cell related applications.
Kumar R, Yeh JJ, Fernandez D, Hansen N.
J Biomol Screen. 2007 Sep;12(6):769-74.
KSR Int'l Co. v. Teleflex, Inc.: no obvious changes for the biotechnology market.
Hinneschiedt CH.
Yale J Biol Med. 2007 Dec;80(4):153-7.
Living tissue and organ donors and property law: more on Moore.
Dickens BM.
J Contemp Health Law Policy. 1992 Spring;8:73-93. No abstract available.
Intellectual Property: a powerful tool to develop biotech research.
Giugni D, Giugni V.
Microb Biotechnol. 2010 Sep;3(5):493-506. doi: 10.1111/j.1751-7915.2010.00172.x. Epub 2010 Jun 1.
Japan's innovators take patent deals to court.
Cyranoski D.
Nature. 2002 Oct 17;419(6908):657. No abstract available.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on